MET and colorectal carcinoma: A key finding was the identification of a transcriptionally and metabolically distinct subpopulation of highly malignant CRC epithelial cells (termed High-M CRC), defined by elevated MYC-driven glycolytic activity and spatial coordination with metabolically active CAFs, particularly mCAFs, via the HGF-MET signaling axis.